Panagora Asset Management’s Niagen Bioscience NAGE Stock Holding History

Panagora Asset Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	347,207 +170,197	+96%	+$691K	﹤0.01%	724
2026 Q1	$781K	Buy	177,010 +4,871	+3%	+$26.3K	﹤0.01%	767
2025 Q4	$1.09M	Hold	172,139	–	–	﹤0.01%	692
2025 Q3	$1.61M	Buy	172,139 +146,684	+576%	+$1.48M	0.01%	565
2025 Q2	$367K	Buy	25,455 +2,474	+11%	+$24.4K	﹤0.01%	881
2025 Q1	$159K	Buy	22,981 +11,157	+94%	+$70.1K	﹤0.01%	1062
2024 Q4	$62.7K	Buy	+11,824	New	+$64.7K	﹤0.01%	1121
2021 Q3	–	Sell	-863	Closed	-$9K	–	2420
2021 Q2	$9K	Sell	863 -145	-14%	-$1.26K	﹤0.01%	2313
2021 Q1	$9K	Hold	1,008	–	–	﹤0.01%	2454
2020 Q4	$5K	Buy	+1,008	New	+$4.91K	﹤0.01%	2485
2017 Q3	–	Sell	-1,132	Closed	-$4K	–	2516
2017 Q2	$4K	Buy	+1,132	New	+$3.59K	﹤0.01%	2531

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Panagora Asset Management's NAGE Position: Q2 2026 in Review

Panagora Asset Management increased its Niagen Bioscience (NAGE) stake by 96% in Q2 2026, buying an estimated $691K and bringing the position to 347,207 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Panagora Asset Management first reported a position in NAGE in Q2 2017 and has held it in 11 quarters since. The position peaked at $1.61M in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Panagora Asset Management held 347,207 shares of Niagen Bioscience worth $1.11M as of Q2 2026.
Panagora Asset Management bought 170,197 Niagen Bioscience shares in Q2 2026, an estimated $691K.
Niagen Bioscience made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #724 holding.
Panagora Asset Management first reported a position in Niagen Bioscience in Q2 2017 and has held it in 11 quarters since.
Panagora Asset Management's Niagen Bioscience position peaked at $1.61M in Q3 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.